TrialJournal of the European Academy of Dermatology and Venereology : JEADV2017

Effect of tofacitinib withdrawal and re-treatment on patient-reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis.

C E M Griffiths et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.